ADARx Pharmaceuticals, Inc. (ADRX) stock
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.30−0.27 (-1.99%)
Close on Nov 11, 2026Market cap –P/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Trading
- Previous close
- $13.57
- Open
- $13.73
- Day's range
- $13.17 – $14.07
- Volume
- 509,963
- Average volume (20 days)
- 389,164
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | ADRX | S&P 500 | Difference | ADRX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -25.2% | -2.4% | −22.8 pts |
ADARx Pharmaceuticals stock: common questions
What is ADARx Pharmaceuticals's stock price?
ADRX closed at $13.30 on Nov 11, 2026, down 1.99% on the day.
Does ADARx Pharmaceuticals pay a dividend?
No. ADARx Pharmaceuticals has not paid a cash dividend over the last twelve months.
Who are ADARx Pharmaceuticals's competitors?
Companies most similar to ADARx Pharmaceuticals by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?